Members of the World Health Organization (who) agreed the text of a legally binding treaty designed to better address future pandemics.

The pandemic agreement aims to avoid disruption and competition for resources observed during the Covid-19 epidemic, as reported by the BBC.

Basics include the rapid exchange of data for new diseases to ensure that scientists and pharmaceutical companies can work faster for the development of treatments and vaccines.

For the first time, the one who will also have an overview of the global supply chains for masks, medical robes and other personal protection equipment (PPAs).

Its general manager, who, Dr. Tedros Antanom Gembregens, described the agreement as “an important milestone in our common journey to a safer world”.

‘Historical Agreement’

The legally binding agreement, reached early on the morning of Wednesday, April 16, came after three years of talks between the Member States.

It is just the second time in its 75 -year history that has been reached by an international agreement of this type – the first was a tobacco control agreement in 2003. However, the agreement remains to be officially approved by members when they meet for the World Health Assembly next month.

US negotiators did not participate in the final discussions after President Donald Trump announced his decision to leave the World Health Organization and the US will not be bound by the agreement when they retired in 2026.

According to the agreed terms, countries should ensure that pandemic -related medicines are available worldwide in a future epidemic.

Particular manufacturers should allocate 10% of their production in vaccines, therapeutic and diagnostic to WHO. Another 10% will then be provided at “affordable prices”.

The countries also approved the transfer of health technologies to poorer countries, provided there is a “mutual agreement”.